EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia

Marina Ribas Losasso iD, Maria Luiza Cesto Parussolo iD, Antony Oliveira Silva iD, Rosa Direito iD, Karina Quesada iD, Claudia Rucco Penteado Detregiachi iD, Marcelo Dib Bechara, Nahum Méndez-Sánchez iD, Ludovico Abenavoli iD, Adriano Cressoni Araújo iD, Ricardo de Alvares Goulart, Elen Landgraf Guiger iD und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104673 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marina Ribas Losasso und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, SP, Brazil. Hauptthemen laut MEDLINE: Sarcopenia, Metabolic Networks and Pathways, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic-Associated Fatty Liver Disease (MAFLD) is a public health concern that is constantly expanding, with a fast-growing prevalence, and it affects about a quarter of the world’s population. This condition is a significant risk factor for cardiovascular, hepatic, and oncologic diseases, such as hypertension, hepatoma, and atherosclerosis. Sarcopenia was long considered to be an aging-related syndrome, but today, it is acknowledged to be secondarily related to chronic diseases such as metabolic syndrome, cardiovascular conditions, and liver diseases, among other comorbidities associated with insulin resistance and chronic inflammation, besides inactivity and poor nutrition. The physiopathology involving MAFLD and sarcopenia has still not been solved. Inflammation, oxidative stress, mitochondrial dysfunction, and insulin resistance seem to be some of the keys to this relationship since this hormone target is mainly the skeletal muscle. This review aimed to comprehensively discuss the main metabolic and physiological pathways involved in these conditions. MAFLD and sarcopenia are interconnected by a complex network of pathophysiological mechanisms, such as insulin resistance, skeletal muscle tissue production capacity, chronic inflammatory state, oxidative stress, and mitochondrial dysfunction, which are the main contributors to this relationship. In addition, in a clinical analysis, patients with sarcopenia and MAFLD manifest more severe hepatitis fibrosis when compared to patients with only MAFLD. These patients, with both disorders, also present clinical improvement in their MAFLD when treated for sarcopenia, reinforcing the association between them. Lifestyle changes accompanied by non-pharmacological interventions, such as dietary therapy and increased physical activity, undoubtedly improve this scenario.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaMetabolic Networks and PathwaysNon-alcoholic Fatty Liver DiseaseFatty LiverHumansInsulin ResistanceOxidative StressAnimalsMuscle, SkeletalMetabolic Syndrome

Stichwörter der Autor:innen

MAFLDcardiovascular diseasesliver diseasemetabolic diseasesmetabolic-associated fatty liver diseasesarcopenia

Autor:innen und Institutionen

  • Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, SP, Brazil.
  • Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines, Universidade de Lisboa (iMed.ULisboa), Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.
  • Postgraduate Program in Structural and Functional Interactions in Rehabilitation, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, SP, Brazil.
  • Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City 14050, Mexico.
  • Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
  • Department of Health Sciences, University "Magna Graecia", Viale Europa, 88100 Catanzaro, Italy.

ORCID-Profile: Marina Ribas Losasso, Maria Luiza Cesto Parussolo, Antony Oliveira Silva, Rosa Direito, Karina Quesada, Claudia Rucco Penteado Detregiachi, Nahum Méndez-Sánchez, Ludovico Abenavoli, Adriano Cressoni Araújo, Elen Landgraf Guiger, Lucas Fornari Laurindo, Sandra Maria Barbalho

Zitieren

APA

Losasso, M. R., Parussolo, M. L. C., Oliveira Silva, A., Direito, R., Quesada, K., Penteado Detregiachi, C. R., Bechara, M. D., Méndez-Sánchez, N., Abenavoli, L., Araújo, A. C., de Alvares Goulart, R., Guiger, E. L., Fornari Laurindo, L., & Maria Barbalho, S. (2025). Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104673

Vancouver

Losasso MR, Parussolo MLC, Oliveira Silva A, Direito R, Quesada K, Penteado Detregiachi CR, et al. Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104673

BibTeX
@article{Losasso2025,
  author = {Losasso, Marina Ribas and Parussolo, Maria Luiza Cesto and Oliveira Silva, Antony and Direito, Rosa and Quesada, Karina and Penteado Detregiachi, Claudia Rucco and Bechara, Marcelo Dib and Méndez-Sánchez, Nahum and Abenavoli, Ludovico and Araújo, Adriano Cressoni and de Alvares Goulart, Ricardo and Guiger, Elen Landgraf and Fornari Laurindo, Lucas and Maria Barbalho, Sandra},
  title = {Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104673}
}
Kostenlos starten →